New Hepatitis C Genotype Test Approved by the FDA
June 24, 2013
FDA approves Abbot Labs hepatitis C genotype test
By The Associated Press
June 20, 2013
The Food and Drug Administration on Thursday approved the first blood test that can identify different strains of the hepatitis C virus to help guide a patient’s treatment.
Abbot Laboratories Inc.’s RealTime HCV Genotype II test is designed to figure out the strain of the virus in patients who are already known to have hepatitis C rather than diagnosing patients with the virus itself. Knowing the type of virus is important because different strains respond differently to the treatments available.
Continue reading this entire article:
Experimental Hepatitis C Drug Not Yet Accepted by FDA
Can Japanese Fresh Water Eels Support Liver Health?